Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEIH.L Regulatory News (EIH)

  • There is currently no data for EIH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of an Investment Manager

18 Jan 2010 07:00

RNS Number : 6719F
EIH PLC
18 January 2010
 



EIH PLC ("EIH" or the "Company)

Appointment of an Investment Manager

EIH is pleased to announce, the appointment of Gateway Asset Management Company Limited ("Gateway") as investment manager to the Companysubject to the finalisation of the commercial terms of the appointment. The appointment supersedes that of Evolvence India Advisors Inc. ("EIA") whose contract terminated on 31st October 2009 and is conditional upon approval by a majority of the shareholders of the Company at an EGM of the Companythe date of which will be announced shortly.

Gateway is to manage the day to day operations of the Company and will work closely with the managers of the Evolvence India Fund ("EIF") and the Evolvence India Life Science Fund ("EILSF") as well as with RSB Group and Gland Pharma the two direct investee companies within the Company's portfolio. It will also cooperate closely with Company's administrator on valuations of the Company's existing portfolio, thereby facilitating the timely production of quarterly NAVs. Assisting the Board with liquidity generation ideas also forms part of the role which, in effect, will take day-to-day executive work and responsibility off the shoulders of the Company's Board, therefore enabling the Board to concentrate on forward strategy, oversight, investor relations and governance. 

Gateway was formed in 2005 and operates out of India and Dubai. Its two principals are Jay Jeganathan, who used to be the CEO of the Company and was originally involved in the establishment of both EIF and the Company, and Ragotham Hayagreevan, who was also involved in the early stages of EIF and is based in Dubai. Both have a strong working knowledge of the existing portfolio and have working relationships with EIA, who manage EIF, the management of EILSF and the senior management of RSB Group and Gland Pharma, the two direct investee companies in the Company's portfolio.

Gateway has been selected after a rigorous evaluation exercise by the Board and it is the intention of the Board that shareholders will have the opportunity of meeting the Gateway team at the proposed EGM of the Company or at one-on-one meetings with shareholders held prior to the proposed EGM of the Company. 

The Company will send shareholders the notice of EGM in due course.

Contacts

EIH plc

William Knight + 44 (0)20 7221 3900

Seymour Pierce Limited (Nominated Adviser and Broker)

Nandita Sahgal + 44 (0)20 7107 8000


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCSFEFWIFSSESF
Date   Source Headline
7th May 202011:49 amRNSResult of EGM and Notice of Cancellation
7th Apr 20207:00 amRNSProposed AIM Cancellation and Notice of EGM
2nd Apr 20205:38 pmRNSReturn of Capital and COVID-19 Update
6th Dec 20197:00 amRNSReturn of Capital
29th Nov 20197:00 amRNSDelisting Update
21st Nov 20197:00 amRNSMarket Update
30th Sep 20194:30 pmRNSInterim Results
30th Jul 201911:15 amRNSResult of AGM
28th Jun 20197:00 amRNSPosting of 2018 Annual Results and Notice of AGM
24th May 20195:53 pmRNSHolding(s) in Company
1st May 20197:00 amRNSReturn of Capital
4th Apr 20195:00 pmRNSSale of RSB and Return of Capital
25th Jan 20197:00 amRNSHolding(s) in Company
21st Jan 20196:13 pmRNSHolding(s) in Company
18th Jan 201911:37 amRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim Results
26th Jul 201811:05 amRNSResult of AGM
28th Jun 20187:00 amRNSPosting of 2017 Annual Report and Notice of AGM
28th Jun 20187:00 amRNSReturn of Capital
20th Mar 20181:00 pmRNSReplacement: Return of Capital
20th Mar 20187:00 amRNSReturn of Capital
29th Sep 20175:17 pmRNSHalf-year Report
29th Sep 20175:13 pmRNSReturn of capital
24th Jul 201710:54 amRNSResults of Annual General Meeting
26th Jun 20176:01 pmRNSDirectorate Change
26th Jun 20176:00 pmRNSPosting of 2016 Annual Report and Notice of AGM
9th Feb 20178:05 amRNSReturn of Capital
26th Jan 20175:08 pmRNSHolding(s) in Company
25th Jan 20179:30 amRNSHolding(s) in Company
5th Jan 20177:00 amRNSUpdate re EIF
30th Sep 20167:00 amRNSHalf-year Report
25th Jul 20161:24 pmRNSResult of AGM
27th Jun 20165:37 pmRNSPosting of Annual Report & Notice of AGM
27th Jun 20167:00 amRNSFinal Results
27th Jun 20167:00 amRNSReturn of Capital
30th Nov 20155:57 pmRNSHolding(s) in Company
30th Sep 20157:00 amRNSInterim Results
30th Jun 201511:53 amRNSResult of AGM
9th Jun 20154:00 pmRNSNotice of AGM
5th Jun 20154:35 pmRNSFinal Results
30th Sep 20147:00 amRNSHalf Yearly Report
14th Jul 20143:19 pmRNSReturn of Capital
30th Jun 201411:57 amRNSResult of AGM
4th Jun 20147:00 amRNSNotice of AGM
3rd Jun 20147:00 amRNSFinal Results
3rd Dec 201311:16 amRNSHolding(s) in Company
2nd Dec 20134:09 pmRNSHolding(s) in Company
28th Nov 20135:14 pmRNSHolding(s) in Company
27th Nov 20133:14 pmRNSSale of Interest in Gland Pharma Limited
22nd Nov 20139:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.